%0 Journal Article
%T ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy
%A Akiva Mintz
%A Benjamin Ellingson
%A Daniel Barboriak
%A Daniel Kim
%A David Mankoff
%A Elizabeth R. Gerstner
%A Erin Greco
%A Eva-Maria Ratai
%A Gregory Sorensen
%A James Fink
%A Kathleen Schmainda
%A Lale Kostakoglu
%A Lucy Hanna
%A Mark Muzi
%A Melissa Prah
%A Ovidiu C. Andronesi
%A Todd Richards
%A Zheng Zhang
%A on behalf of the ACRIN 6684 trial group
%J Archive of "PLoS ONE".
%D 2018
%R 10.1371/journal.pone.0198548
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002091/